COVID Test Co. Will Pay $500K To End SEC Fraud Claims
A New York medical diagnostic tests manufacturer has agreed to pay the U.S. Securities and Exchange Commission $500,000 to end claims it misled investors when the company raised over $30 million...To view the full article, register now.
Already a subscriber? Click here to view full article